• 1. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 2. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 3. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 4. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

Comprehensive Guide to 4,6-Dimethylpyridine-3-boronic Acid Pinacol Ester (CAS No. 1622217-32-6): Properties, Applications, and Industry Insights

4,6-Dimethylpyridine-3-boronic Acid Pinacol Ester (CAS No. 1622217-32-6) is a high-value boronic ester derivative widely utilized in pharmaceutical research, organic synthesis, and material science. This compound belongs to the pyridine-boronic acid family, known for its stability and versatility in Suzuki-Miyaura cross-coupling reactions, a cornerstone of modern drug discovery. With the rise of targeted drug development and green chemistry, demand for specialized boron-containing intermediates like this has surged, making it a focal point for researchers and manufacturers alike.

The molecular structure of 4,6-Dimethylpyridine-3-boronic Acid Pinacol Ester features a pinacol-protected boronate group at the 3-position of a dimethyl-substituted pyridine ring. This design enhances its shelf stability while maintaining reactivity under catalytic conditions. Recent studies highlight its role in synthesizing heterocyclic compounds, particularly in oncology and CNS drug candidates. A 2023 Journal of Medicinal Chemistry report emphasized its utility in constructing kinase inhibitor scaffolds, addressing trending searches like "next-generation cancer therapeutics" and "small molecule drug design."

From an industrial perspective, this compound aligns with the growing emphasis on sustainable synthetic routes. Its compatibility with palladium-free coupling systems answers frequent queries about "transition metal alternatives in catalysis." Manufacturers now prioritize high-purity grades (≥98%) to meet stringent GMP standards, reflecting the pharmaceutical industry's shift toward quality-by-design (QbD) principles – a hot topic in process chemistry forums.

Analytical characterization of CAS No. 1622217-32-6 typically involves HPLC-MS and NMR spectroscopy, with particular attention to boron-11 NMR for verifying ester integrity. Storage recommendations (-20°C under inert gas) frequently appear in technical FAQs, underscoring users' concerns about compound stability. Notably, its low hygroscopicity compared to free boronic acids makes it preferable for automated synthesis platforms – a key advantage for labs investing in high-throughput screening infrastructure.

Emerging applications include OLED material synthesis, where its electron-deficient pyridine core contributes to charge transport layers. This connects with booming interest in "organic electronic materials" and "flexible display technologies." Patent analyses reveal a 40% increase in filings referencing this compound since 2020, particularly in photovoltaic materials and bioimaging probes – areas dominating materials science search trends.

For procurement specialists, understanding supply chain dynamics is crucial. Major producers have implemented just-in-time manufacturing to address the compound's specialty chemical status. Pricing trends correlate with boron feedstock availability, a topic gaining traction amid discussions about critical raw material security. Regulatory-wise, proper REACH compliance documentation remains essential, reflecting the industry's focus on regulatory preparedness in chemical sourcing.

In academic settings, 4,6-Dimethylpyridine-3-boronic Acid Pinacol Ester serves as an excellent case study for organoboron chemistry courses. Its crystallographic data (CCDC-deposited) facilitates molecular modeling exercises, addressing pedagogical searches like "teaching Suzuki coupling" and "hands-on medicinal chemistry." The compound's moderate polarity also makes it ideal for demonstrating chromatographic purification techniques.

Future directions may involve continuous flow chemistry adaptations, as evidenced by recent microwave-assisted coupling studies. With the boron therapeutics market projected to reach $2.5B by 2027 (Grand View Research), derivatives like this will likely see expanded use in proteolysis-targeting chimeras (PROTACs) and covalent inhibitor development – two of the most searched drug modality topics today.

• 2223041-94-7(4-Methyl-6-(iso-butyl)pyridine-3-boronic acid pinacol ester)
• 693774-10-6(2,6-Dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 1309980-12-8(2,5-dimethyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 1012084-56-8(2-Methylpyridine-3-boronic acid, pinacol ester)
• 1421252-89-2(2,4-dimethyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 2009346-30-7(4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carbonitrile)
• 2096330-85-5(4-ethylpyridine-3-boronic acid pinacol ester)
• 610768-32-6(2-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 1171891-31-8(4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 2096331-29-0(Pyridine, 2,4,6-trimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-)